Rat Model Market 2020-2026
Global Rat Model Market Size, Share & Trends Analysis Report by Technology (Micro Injection, Embryonic Stem Cell Injection, Nuclear Transferase Technology, and CRISPR), By Type (Inbred Rats, Knockout Rats, Outbred Rats, and Others), Forecast Period 2020-2027
The global rat model market is projected to grow at a significant CAGR during the forecast period. The major factors that are augmenting the growth of the market include the increasing investment by the pharma companies in R&D coupled with the increasing demand for personalized drugs. The rat model is used in many applications such as diabetes, toxicology, immunology, oncology, neurology, and infectious disease as well as some rare disease. The growing production of monoclonal antibodies further gives a boost to the growth of the global rat model market. However, certain factors are affecting the growth of the market negatively such as rules and regulations & laws formulated by the government organizations such as the Animal welfare Act (AWA), and the Public health care policy (PHS) for the ethical use of animals in research and human care.
The global rat model market is segmented based on technology and type. By technology, the market is segmented into microinjection, embryonic stem cell injection, nuclear transferase technology, and CRISPR. Further, based on the type, the market is segmented into inbred rats, outbred rats, knockout rats, and others such as hybrid rats.
Global Rat Model Market Share by Technology, 2020 (%)
Source: OMR Global
CRISPR technology is projected to contribute a prominent share in the global market owing to its high use. In addition, the increasing demand for genetically modified animals creates demand for CRISPR technology for various applications within the rat-based research activity.
Rat Model Type Insights: Outbred Models to Contribute Significantly to the Market Growth
Various rat models are available for research such as the inbred rat model, outbred rat model, knockout rat model, and others. The outbred type is projected to contribute a significant share in the global market. Outbred rat models allow in-depth research and further help in predicting variations in reactions for the same drug by individual animals. This model is mostly supplied by commercial breeding firms. However, there are few types of models such as knockout and hybrid that are gaining popularity over the outbred models.
The global rat model market is analyzed based on the geographical regions contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. North America is estimated to contribute a prominent share in the global rat model market. The region, especially the And country has the highest spending on R&D, which is one of the major factors driving the regional growth of the market.
Global Rat Model Market Growth by Region, 2020-2027
Source: OMR Global
Market Players Outlook
Moreover, the report covers the analysis of various players operating in the market. Some of the key players covered in the report include Charles River Laboratories Inc., Envigo, GenOway S.A., Braintree Scientific, Inc., Covance Inc., Ingenious Targeting Laboratory, Taconic Biosciences, Inc., and others. To survive in the market, these players adopt different marketing strategies such as mergers, acquisitions, product launches, and geographical expansion. For instance:
In January 2020, Charles River Laboratories International, Inc. announced that it has completed the acquisition of HemaCare Corp. to expand its capabilities in the emerging, high-growth cell therapy sector. With this acquisition, HemaCare became part of Charles River's Research Models and Services segment.
In November 2019, Envigo RMS LLC, a global supplier of research models and associated services announced an agreement to acquire the assets of the research model business unit of Horizon Discovery Group plc. Horizon's research models business unit, which provides genetically engineered models and services transferred to Envigo ownership. The business unit uses gene-editing technology and expertise for producing customized models with relevant gene deletions, insertions, and other modifications, which are then used as models for human disease during drug discovery and development.
The Report Covers
Market value data analysis of 2019 and forecast to 2026.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global rat model market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where in the market.